FDA Investigator Michael A Feingold
Michael A Feingold has conducted inspections on 187 sites in 7 countries as of 04 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
187
Last Inspection Date:
04 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Ireland,
Belgium,
Italy,
France,
Japan
FDA Investigators that have inspected at least one site in common with Michael A Feingold:
Adree N Anderson,
Adrienne Morgan,
Alan E Mehl,
Alicia M Frees,
Alvaro G Dominguez, Jr,
Alysia C Alger,
Amir A Abdalla,
Andrew A Hoopes,
Andrew F Cohen,
Andrew K Schaal,
Anna L Tucker,
Aqualia L Nelson,
Ashlee M Ward,
Ashley A Mutawakkil,
Ava M Collins,
Avery J Dennis,
Barbara I Rogolsky,
Barbara Janine Breithaupt,
Bonnie E Pierson,
Brenda C Hamilton,
Brent T Hall,
Brett R Havranek,
Brian R Yaun,
Brian Ravitch,
Brittany D Terhar,
Bruce E Taylor,
Candace S Tucker,
Carl J Montgomery,
Carmen Y Fisher,
Catherine R Olguin,
Chad W Rice,
Christopher D Snyder,
Cody D Rickman,
Cody J Alley,
Collins M Mason,
Craig Farmer,
Cynthia M Goudeau,
Dana D Carter, SR DDS,
Danial S Hutchison,
Darrah,
Darrin W Freeman,
Deidre R Edwards,
Desiree C Iya,
Diana K Krepel,
Diana M Guidry,
Dustin K Hampton,
Dwight D Ferguson,
Edith M Gonzalez,
Edna J Hidalgo,
Edward E Lockwood (EEL),
Elizabeth P Mayer,
Eric C Nielsen,
Eric M Mueller, PharmD,
Eric M Padgett,
Eric Rothschild,
Erika V Butler,
Erin C Dugan,
Erin M Hale,
Esther A Ofori,
Francis W Yomi,
Gale L Glinecki,
Gretchen Lf Trendel,
Gwyn G Dickinson,
Heath W Cartwright,
Hiwot A Kesi,
Huffmanc,
Ingrid Y Johnson,
James J Houlihan,
James R Betz,
Jamie E Spencer,
Janesa A Licorish,
Janet B Abt,
Janete A Eaker,
Janete A Oliveira,
Janna C Hutchinson,
Jason H Wieners,
Jeffery A Hangartner,
Jeffrey B Moody,
Jennifer Cahill,
Jessica E Hensley,
Jessica L Peterson,
John A Iwen,
Johnson,
Jonathan R Campos,
Joselin P Baray Alvarado,
Joseph R Lambert,
Joshua C Schafer,
Julie N Vosilus,
Kamara Mo,
Kara L Roden,
Karen C Daugherty,
Karen M Montgomery (KMM),
Katherine M Taylor,
Kathleen B Swat,
Kathleen J Close,
Kathryn A Bushur,
Kellia N Hicks,
Kevin A Beavers,
Kimberlee A Ewing,
Kristi B Panzer,
Laura E Mcneil,
LCDR Ismael Olvera, IV,
LCDR Matthew J Morrison,
Linda K Cline,
Lindsay P Williams,
Linhart,
Lionell L Thomas,
Lisa D Ellis,
Lisa L Flores,
Lloyd M Luapula,
Lori A Gioia,
Louis S Chen,
Lyndsey G Smith,
Marion D Wimberly, Jr,
Martin J Kurek,
Matthew A Walburger,
Megan E Kulas,
Megan M Jekel,
Meisha Waters,
Melinda L Rice,
Melissa B Libby,
Melissa N Simanton,
Melissa N Wilson,
Melva J Palmer,
Meredith P Soehl, Investigator,
Michael S Kopf,
Michele Perry Williams,
Michelle C Webb,
Minerva Rogers,
Monica M Mcclure,
Monique M Brooks,
Nadine Nanko Johnson,
Nancy G Schmidt,
Nankon,
Naseem S Jouhari,
Nia K Walker,
Nicole C Mayfield,
Nicole J Conklin,
Paige E Shelborne,
Paige E Wilson,
Paul Klug,
Pedro A Cruz,
Peter E Gruman,
Ponzoj,
Rachelle Kuster,
Rashonda N Rucker,
Raymond M Lam,
Raymond T Anderson,
Rendall E Barfoot,
Rene M Amaguana,
Richard D Coleman,
Robert D Ogan,
Rodney D Combs,
Ron R Pearson,
Ryan S Martin,
Samuel K Gibbons, Jr,
Sarah E Morris,
Scott A Jepson,
Shafiq S Ahadi,
Shanna R Haden,
Shaun M Olson,
Shaun M Stracener,
Sondra L Phillips,
Sonia D Hudson,
Steven P Allen,
Steven W Brown,
Stroman,
Tamara J Genetti,
Tamara J Umscheid,
Tara J Nickel,
Tara L Greene,
Tara M Aikens,
Tara M Humfeld,
Teresa S Johnson,
Thuy T Nguyen, LCDR,
Tristian E Strait,
Valeria A Moore,
Vanessa J Stefka,
Victoria A Wagoner,
Walsworth,
Warren J Lopicka,
Wayne D Mcgrath,
Weston K Szymanski,
William C Corley,
William F Lagud, Jr,
Zachary A Bogorad
Michael A Feingold's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2016 | FDA 483 Response | Aspen Hills, Inc. - Form 483R, 2016-10-06 |
October, 2016 | FDA 483 | Aspen Hills, Inc. - Form 483, 2016-10-06 |
June, 2022 | FDA 483 | ByHeart Inc dba Blendhouse Allerton - Form 483, 2022-06-30 |
August, 2018 | FDA 483 | D & D Foods, Inc. - Form 483, 2018-08-07 |
July, 2018 | FDA 483 | IRCA Group USA LLC - Form 483, 2018-07-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more